LAVA Therapeutics NV Cash Flow Reinvestment Rate
LAVA Therapeutics NV cash flow reinvestment rate. LAVA Therapeutics NV (LVTX) has a Cash Flow Reinvestment Rate of 0.12x as of December 2022, reinvesting $4.40 Million (capex $265.00K plus investments $-4.14 Million) from operating cash flow of $35.73 Million. Explore LVTX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of LAVA Therapeutics NV (2022–2022)
Cash flow reinvestment rate of LAVA Therapeutics NV from 2022 to 2022. Historical reinvestment intensity for LAVA Therapeutics NV across 1 annual periods. Explore LAVA Therapeutics NV capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
LAVA Therapeutics NV Cash Flow Reinvestment Rate by Year (2022–2022)
LAVA Therapeutics NV cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for LAVA Therapeutics NV. For the full cash flow conversion analysis, see LAVA Therapeutics NV cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.46x | $9.93 Million | $4.04 Million | $587.00K | — |